(Q28385659)

25 June 2017

title

Inhibition of phosphodiesterase 10A has differential effects on dopamine D1 and D2 receptor modulation of sensorimotor gating (English)

1 reference

25 June 2017

1 reference

4

Victoria B Risbrough

1 reference

25 June 2017

Jodi E Gresack

1

1 reference

25 June 2017

Patricia A Seymour

series ordinal

2

1 reference

25 June 2017

Christopher J Schmidt

series ordinal

3

1 reference

25 June 2017

language of work or name

English

0 references

publication date

21 December 2013

1 reference

25 June 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Psychopharmacology

1 reference

25 June 2017

volume

231

1 reference

25 June 2017

issue

10

1 reference

25 June 2017

page(s)

2189-2197

1 reference

Stereochemical and neuroanatomical selectivity of pramipexole effects on sensorimotor gating in rats

25 June 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Mechanisms for the Modulation of Dopamine D1 Receptor Signaling in Striatal Neurons

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Striatal medium-sized spiny neurons: identification by nuclear staining and study of neuronal subpopulations in BAC transgenic mice

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Evaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverine

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Realistic expectations of prepulse inhibition in translational models for schizophrenia research

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Phosphodiesterases in the CNS: targets for drug development

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A)

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Immunohistochemical localization of PDE10A in the rat brain

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Mouse pharmacological models of cognitive disruption relevant to schizophrenia

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

PDE10A Inhibitors: Novel Therapeutic Drugs for Schizophrenia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Pergolide treatment of cognitive deficits associated with schizotypal personality disorder: continued evidence of the importance of the dopamine system in the schizophrenia spectrum

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

PDE10A inhibitors: an assessment of the current CNS drug discovery landscape.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

The antipsychotic potential of l-stepholidine--a naturally occurring dopamine receptor D1 agonist and D2 antagonist

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Phosphodiesterase 10A inhibitors: a novel approach to the treatment of the symptoms of schizophrenia.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Reduced startle gating after D1 blockade: effects of concurrent D2 blockade

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Half a century of antipsychotics and still a central role for dopamine D2 receptors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Do D1/D2 interactions regulate prepulse inhibition in rats?

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle

2 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3371-7

The effect of a full agonist/antagonist of the D1 receptor on locomotor activity, sensorimotor gating and cognitive function in dizocilpine-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3371-7

D1 and D2 dopamine receptor antagonists reverse prepulse inhibition deficits in an animal model of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3371-7

Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3371-7

Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3371-7

Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3371-7

Amelioration of ketamine-induced working memory deficits by dopamine D1 receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3371-7

PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3371-7

Increased social interaction in mice deficient of the striatal medium spiny neuron-specific phosphodiesterase 10A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3371-7

The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3371-7

Phosphodiesterase 10A inhibition modulates the sensitivity of the mesolimbic dopaminergic system to D-amphetamine: involvement of the D1-regulated feedback control of midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3371-7

Role of basolateral amygdala dopamine in modulating prepulse inhibition and latent inhibition in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3371-7

Alterations in gene regulation following inhibition of the striatum-enriched phosphodiesterase, PDE10A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3371-7

Forebrain D1 function and sensorimotor gating in rats: effects of D1 blockade, frontal lesions and dopamine denervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3371-7

Cyclic adenosine monophosphate-independent tyrosine phosphorylation of NR2B mediates cocaine-induced extracellular signal-regulated kinase activation.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017785

Emerging drugs for schizophrenia

27 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24363077

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00213-013-3371-7

1 reference

Dimensions Publication ID

25 June 2017

1024793378

0 references

Fatcat ID

release_2c5ys2ubpjgxdb5tyuy7f2mr3i

0 references

OpenCitations bibliographic resource ID

4915363

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4915363

1 reference